HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 17 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 1 | -99.9% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 1,001 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,001 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -83.3% | 1,001 | -77.8% | 0.00% | – |
| Q1 2022 | $6,000 | +20.0% | 4,501 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -50.0% | 4,501 | -30.8% | 0.00% | -100.0% |
| Q3 2021 | $10,000 | -23.1% | 6,501 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $13,000 | +116.7% | 6,501 | +116.6% | 0.00% | – |
| Q1 2021 | $6,000 | – | 3,001 | +300000.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 57,309 | $178,000 | 0.03% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 15,552 | $48,000 | 0.00% |
| Squarepoint Ops LLC | 15,524 | $48,000 | 0.00% |
| ExodusPoint Capital Management, LP | 11,632 | $36,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 33,215 | $103,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 57 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,786 | $49,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 29,233 | $91,000 | 0.00% |
| MORGAN STANLEY | 54 | $0 | 0.00% |